Palatin (PTN) 10-K2024 FY Annual report

Filed: 30 Sep 24, 4:31pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abeyance, accuracy, AI, Altimmune, analog, avanafil, baseline, biased, CDMO, circumvention, climate, combat, compounded, concurrent, confidence, confirming, Cosette, cybersecurity, degrader, deployed, disciplinary, easily, Edgewise, Eli, EWTX, fashion, glue, Guide, hasincurred, herding, Highbridge, hyperactive, illegitimate, Imcivree, implicate, impracticable, Improper, improperly, inaccuracy, inaccurate, ineffective, ineligible, intelligence, ITT, Levitra, Likewise, Lilly, male, Merck, merit, monogenic, monotherapy, Nordisk, Novo, older, outsourced, overbroad, Ozempic, pain, pediatric, permanent, pharmacovigilance, phosphodiesterase, physical, platform, proactively, properly, provenance, reclassified, Recovery, refractory, Regeneron, Rhythm, Rosa, Sanofi, score, SCPX, segment, semaglutide, setmelanotide, sildenafil, simultaneously, Stendra, symptom, synergistic, tadalafil, tirzepatide, undetected, unregistered, unusual, usage, vardenafil, vehicle, Viagra, visual, weather, Wegovy

Removed: absolute, alcohol, antagonist, applying, Asia, assay, assessed, assumed, avoided, bedtime, bid, blood, Boxed, breast, breastfed, call, capability, cardiovascular, clarify, close, cohort, contraindicated, COSO, darkening, detected, digit, discontinue, disposable, diversity, downturn, dramatically, drink, drinking, dropping, excellent, exclusively, fill, flushing, focal, forecasted, forecasting, format, Framework, freestanding, FSD, gingiva, headache, heart, highest, highlight, home, Hong, hyperpigmentation, hypertension, hypotension, immunotherapy, impede, infant, inherently, interaction, Kong, lactating, launch, licensed, liver, long, lost, Macau, maternal, Maximizing, media, milk, mitigation, modification, nausea, observational, obstetrical, operated, ordering, pen, placebo, play, postmenopausal, pregnancy, pregnant, realize, Restoration, restore, retrospective, rodent, route, serotonin, simulation, skin, skip, Sponsoring, Sprout, stabilize, successive, superior, supporting, syncope, Taiwan, territory, testosterone, tied, transient, Treadway, uncontrolled, unexposed, unreliable, vomiting, weakened

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated PTN transcripts

PTN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (Nos. 333-275883 and 333-277934) on Form S-1, (Nos. 333-33569, 333-56605, 333-64951, 333-72873, 333-84421, 333-52024, 333-54918, 333-74990, 333-100469, 333-101764, 333-104370, 333-112908, 333-128585, 333-132369, 333-140648, 333-146392, 333-174251, 333-183837, 333-185113, 333-201821, 333-206003, 333-206047, 333-226905, and 333-262555) on Form S-3 and (Nos. 333-57079, 333-83876, 333-128854, 333-149093, 333-163158, 333-174257, 333-191467, 333-206009, 333-214618, 333-221554, 333-227354 and 333-267615) on Form S-8 of our report dated September 30, 2024, with respect to the consolidated financial statements of Palatin Technologies Inc. and subsidiary.

/s/ KPMG LLP

Philadelphia, Pennsylvania
September 30, 2024